Stay updated with breaking news from Syn One Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A commercially available skin test to aid Parkinson's disease diagnosis is available in most states. How do clinicians use it? Could it help in the development of alpha-synuclein-targeted therapies?
Hosted by AZBio CEO Joan Koerber-Walker, the 2023 AZBio Awards honored the most innovative bioscience leaders and companies in Arizona.
/PRNewswire/ -- CND Life Sciences, a medical technology company pioneering the development of skin-based tests to help clinicians diagnose neurodegenerative...
/PRNewswire/ -- CND Life Sciences, a medical technology company pioneering the development of cutaneous neurodiagnostics, today announced topline results from...
CND raised an additional $1 million in venture financing from Top Corner CapitalSCOTTSDALE, Ariz., April 6, 2023 /PRNewswire/ -- CND Life Sciences...